1500 E. Medical Center Drive 1910 TC
Ann Arbor, MI 48109
Available to mentor
Dr. Kelly Harms, MD, PhD, is a Clinical Associate Professor in the Department of Dermatology at the University of Michigan. She serves as chief of cutaneous surgery and oncology and as director of the Multidisciplinary Cutaneous Oncology Program at Michigan Medicine. Dr. Harms was appointed as Lewis and Lillian Becker Professor of Dermatology on April 1, 2022.
Dr. Harms provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the UM Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.
Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the University of Michigan Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our multidisciplinary skin cancer programs.
Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy.
-
Harms PW, Runge M, Chan MP, Liu C-J, Qin Z, Worden F, Robinson DR, Chinnaiyan AM, Mclean SA, Harms KL, Fullen DR, Patel RM, Andea AA, Udager AM. Mod Pathol, 2024 Aug 21; 37 (11): 100592Journal ArticleSquamoid Eccrine Ductal Carcinoma Displays Ultraviolet Mutations and Intermediate Gene Expression Relative to Squamous Cell Carcinoma, Microcystic Adnexal Carcinoma, and Porocarcinoma.
DOI:10.1016/j.modpat.2024.100592 PMID: 39154783 -
Wenzel D, Schuler AM, Smith DC, Evans JR, Harms KL, Pedersen EA. JAAD Case Rep, 2024 Oct; 52: 112 - 115.Journal ArticleCirculating tumor DNA is a useful adjunct for Merkel cell carcinoma monitoring in the context of multiple metastatic malignancies.
DOI:10.1016/j.jdcr.2024.07.026 PMID: 39385809 -
Fayne R, Ahn JW, Harms KL. JAAD Case Rep, 2024 Oct; 52: 52 - 54.Journal ArticleErythematous plaque in the axilla.
DOI:10.1016/j.jdcr.2024.07.005 PMID: 39286827 -
Durgin JS, Whittington CP, Joseph M, Harms PW, Andea AA, Pedersen EA, Smith EH, Harms KL. J Cutan Pathol, 2024 Jul; 51 (7): 490 - 495.Journal ArticleMultiple primary dermatofibrosarcoma protuberans tumors in a single patient with chromosomal microarray analysis: A case report and review.
DOI:10.1111/cup.14612 PMID: 38548658 -
2024 May 4;PresentationThe “Art of the Possible” in a Rare Disease
-
2024 May 2;PresentationEvidence Based Management of Rare Tumors
-
Greene RK, Gangidi S, Zhao R, Nelson JM, Harms K, Nakamura M. Pediatr Dermatol, 2024 41 (4): 660 - 666.Journal ArticleThe relationship between acrochordons, obesity, and metabolic syndrome in the pediatric population: A retrospective cohort study.
DOI:10.1111/pde.15639 PMID: 38684337 -
Harms K. 2024 Mar 11;PresentationMerkel Cell Carcinoma: Diagnosis, Management, and Controversies